[
    "{\"step_by_step_thinking\": \"The Oncotype DX test is a genomic test used in clinical practice to predict the risk of disease recurrence in estrogen receptor (ER)-positive, lymph node-negative, or lymph node-positive early breast cancer patients who are receiving endocrine therapy. It is used to guide treatment decisions in women with hormone receptor-positive, lymph node-negative, or lymph node-positive early breast cancer. The test is used to determine the benefit of chemotherapy for breast cancer in early stages. Therefore, the test is done to guide the decision for chemotherapy in hormone receptor positive patients.\", \"answer_choice\": \"A\"}"
]